Patient Preference and Adherence · 2017 · 33 citations · 43 references
Public HealthInfectious DiseasesPharmacotherapyClinical PharmacologyHiv ControlHiv PreventionAntiretroviral TherapyAntiviral TherapyHiv EpidemiologyHuman Immunodeficiency Virus PharmacotherapyTreatment AdherenceAdherenceAdherence In Hiv TreatmentCd4 Cell Count MonitoringHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyMother-to-child Hiv Transmission
Background: Reasons for and frequency of nonadherence to antiretroviral therapy (ART) may have changed due to pharmacological improvements. In addition, the importance of known non-pharmacologic reasons for nonadherence is unclear. Methods: We performed a cross-sectional, noninterventional, multicenter study to identify current reasons for nonadherence. Patients were categorized by physicians into the following adherence groups: good, unstable, or poor adherence. Co-variables of interest included age, sex, time since HIV diagnosis, ART duration, current ART regimen, HIV transmission route, comorbidity, HIV-1 RNA viral load (VL), and CD4 cell count. Patients self-reported the number of missed doses and provided their specific reasons for nonadherent behavior. Statistical analyses were performed using Fisher’s extended exact test, Kruskal–Wallis test, and logistic regression models. Results: Our study assessed 215 participants with good (n=162), unstable (n=36), and poor adherence (n=17). Compared to patients with good adherence, patients with unstable and poor adherence reported more often to have missed at least one dose during the last week (good 11% vs unstable 47% vs poor 63%, p <0.001). Physicians’ adherence assessment was concordant with patients’ self-reports of missed doses during the last week (no vs one or more) in 81% cases. Similarly, we found a strong association of physicians’ assessment with viral suppression. Logistic regression analysis showed that “reduced adherence” – defined as unstable or poor – was significantly associated with patients <30 years old, intravenous drug use, history of acquired immune deficiency syndrome (AIDS), and psychiatric disorders ( p <0.05). Univariate analyses showed that specific reasons, such as questioning the efficacy/dosing of ART, HIV stigma, interactive toxicity beliefs regarding alcohol and/or party drugs, and dissatisfaction with regimen complexity, correlated with unstable or poor adherence ( p <0.05). Conclusion: Identification of factors associated with poor adherence helps in identifying patients with a higher risk for nonadherence. Reasons for nonadherence should be directly addressed in every patient, because they are common and constitute possible adherence intervention points. Keywords: human immunodeficiency virus, HIV, antiretroviral therapy, ART, adherence, nonadherence, patients’ beliefs
43
Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine · 2005 · 7.9K citations
Julia H. Arnsten, Penelope Demas, Homayoon Farzadegan et al. · Clinical Infectious Diseases · 2001 · 648 citations · Full text
Public Health, Pharmacotherapy, Electronic Health Records +15
Sharon Mannheimer, Gerald Friedland, John P. Matts et al. · Clinical Infectious Diseases · 2002 · 529 citations